Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sasha R Douglas

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Journal of Surgical Research|July 27, 2021
Identification of CD105+ Extracellular Vesicles as a Candidate Biomarker for Metastatic Breast CancerSasha R Douglas, Kay T Yeung, Jing Yang, et al.
Annals of Surgical Oncology|September 20, 2025
Neoadjuvant Endocrine Therapy Use in Estrogen Receptor Positive Breast Cancer: Insights from Practice Shifts During the COVID-19 PandemicSasha R Douglas, Samantha M Thomas, Astrid Botty van den Bruele, et al.
Surgical Oncology|May 24, 2022
National Cancer Database trends in surgical resection of the breast primary for stage IV breast cancerSasha R Douglas, Ingrid M Lizarraga, Judy C Boughey, et al.
Annals of Surgical Oncology|September 23, 2025
Contemporary Trends in Axillary Surgery for ER-Positive, HER2-Negative Breast Cancer Stratified by Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, or Upfront SurgerySasha R Douglas, Samantha M Thomas, Akiko Chiba, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Journal of Surgical Research|July 27, 2021
Identification of CD105+ Extracellular Vesicles as a Candidate Biomarker for Metastatic Breast CancerSasha R Douglas, Kay T Yeung, Jing Yang, et al.
Annals of Surgical Oncology|September 20, 2025
Neoadjuvant Endocrine Therapy Use in Estrogen Receptor Positive Breast Cancer: Insights from Practice Shifts During the COVID-19 PandemicSasha R Douglas, Samantha M Thomas, Astrid Botty van den Bruele, et al.
Surgical Oncology|May 24, 2022
National Cancer Database trends in surgical resection of the breast primary for stage IV breast cancerSasha R Douglas, Ingrid M Lizarraga, Judy C Boughey, et al.
Annals of Surgical Oncology|September 23, 2025
Contemporary Trends in Axillary Surgery for ER-Positive, HER2-Negative Breast Cancer Stratified by Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, or Upfront SurgerySasha R Douglas, Samantha M Thomas, Akiko Chiba, et al.
Pageof 1